Ginkgo snaps up synbio rival Zymergen for $300m - BioPharma-Reporter

Retrieved on: 2022-07-25 22:41:14

Tags for this article:

Click the tags to see associated articles and topics

Ginkgo snaps up synbio rival Zymergen for $300m - BioPharma-Reporter. View article details on hiswai:

Excerpt

Boston based Ginkgo Bioworks is acquiring California headquartered, Zymergen, for $300m, making it the company's largest acquisition to date.

Article found on: www.biopharma-reporter.com